International Journal on Magnetic Particle Imaging IJMPI
Vol. 11 No. 1 Suppl 1 (2025): Int J Mag Part Imag
https://doi.org/10.18416/IJMPI.2025.2503006
Magnetic particle spectroscopy based biosensing platform for nucleic acids detection
Main Article Content
Copyright (c) 2025 Florian Wolgast, Rebecca Sack, Yihao Wang, Rabia Amin, Mohammad Suman Chowdhury, Aidin Lak, Meinhard Schilling, Thilo Viereck

This work is licensed under a Creative Commons Attribution 4.0 International License.
Abstract
Reliable nucleic acid assays are essential for modern laboratory diagnostics. Due to the complex and numerous steps involved, polymerase chain reaction, the current gold standard in nucleic acid detection, is not suitable for point-of-care (POC) diagnostics. Assays based on magnetic nanoparticles (MNPs) and magnetic particle spectroscopy (MPS) are wash- and enzyme-free and combine signal amplification with a benchtop device, thus fulfilling all the requirements to close this gap. Our nucleic acids biosensing platform enables the specific detection of DNA in concentrations of less than 27 pM as well as the enzyme-free detection of viral RNA in combination with a highly sensitive MPS device with cost-effective technology.
Article Details
References
[2] F. T. Wolgast et al., Low-Cost Magnetic Particle Spectroscopy Hardware for Low-Viral-Load Immunoassays, IEEE Trans. Instrum. Meas. vol. 73, pp. 6008509, August 2024.
[3] P. Vogel et al., Critical Offset Magnetic Particle Spectroscopy for rapid and highly sensitive medical point-of-care diagnostics, Nat. Commun, vol. 13, pp. 7230, November 2022.